Revascularization for multivessel disease: Getting closer, but…

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Cardiac Surgery

Background:

• Multivessel coronary artery disease requires revascularization strategies, primarily Percutaneous Coronary Intervention (PCI) and Coronary Artery Bypass Grafting (CABG).
• Registry data provides real-world insights into the comparative effectiveness and long-term outcomes of these revascularization methods.

Discussion:

• While both PCI and CABG demonstrate comparable short-term risks for major adverse cardiovascular events (death, myocardial infarction, stroke), long-term outcomes differ.
• A key difference lies in the need for subsequent interventions, with PCI associated with a higher rate of return to the cardiac catheterization laboratory for further PCI or even repeat CABG.

Key Insights:

• For multivessel disease, PCI and CABG present similar immediate risks of mortality, myocardial infarction, and stroke.
• PCI necessitates a higher likelihood of follow-up procedures compared to CABG, impacting long-term management and resource utilization.

Outlook:

• Further research should focus on patient selection criteria to optimize the choice between PCI and CABG for multivessel disease.
• Investigating the economic and quality-of-life implications of repeat procedures following PCI is crucial for comprehensive treatment planning.